Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K
1.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
1.8K
Abnormal Proliferation02:23

Abnormal Proliferation

5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.0K
6.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-Omic Landscape of Gastrointestinal Stromal Tumors in a Real-World Patient Cohort of 1,427 Cases.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Advances in Radiation Therapy for Primary Bone Malignancies.

Technology in cancer research & treatment·2026
Same author

Adjuvant Imatinib or Observation in Patients With Gastrointestinal Stromal Tumors With KIT Exon 9 Mutations.

JAMA oncology·2026
Same author

Impact of nurse navigation and mobile app on brain tumor patients receiving oral anticancer therapy.

NPJ digital medicine·2026
Same author

Tumor Genomics, Metastatic Patterns, and Prognosis in Leiomyosarcoma: A Single-Center Retrospective Cohort Study.

Cancers·2025
Same author

DNA Damage Repair Pathway Alterations and Immune Landscape Differences in Pediatric/Adolescent, Young Adult (AYA) and Adult Sarcomas.

Cancers·2025

Related Experiment Video

Updated: Apr 12, 2026

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

7.7K

Rhabdomyosarcoma in adults: new perspectives on therapy.

Catalina Ruiz-Mesa1, John M Goldberg, Alvaro J Coronado Munoz

  • 1Department of Pediatrics, University of Miami/Holtz Children's Hospital at Jackson Health System, 1611 NW 12th Ave, Holtz Hospital 6th floor, Miami, FL, 33136, USA, catalina.ruizmesa@jhsmiami.org.

Current Treatment Options in Oncology
|May 16, 2015
PubMed
Summary

Rhabdomyosarcoma (RMS) is a pediatric cancer, but adult cases, especially pleomorphic RMS, lack understanding and standardized treatments. Further research is crucial to improve survival rates for adult RMS patients.

More Related Videos

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

3.0K
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.8K

Related Experiment Videos

Last Updated: Apr 12, 2026

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

7.7K
Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

3.0K
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.8K

Area of Science:

  • Pediatric Oncology
  • Medical Genetics
  • Cancer Biology

Background:

  • Rhabdomyosarcoma (RMS) is primarily recognized as a pediatric malignancy, with extensive research focusing on its biology, genetics, and treatment in children.
  • Significant survival improvements in pediatric RMS over the past two decades are attributed to well-described subtypes like embryonic and alveolar RMS.
  • Adult RMS, particularly the pleomorphic subtype, is rare, presenting challenges in research and understanding its unique biological and genetic characteristics.

Purpose of the Study:

  • To highlight the knowledge gaps in adult Rhabdomyosarcoma (RMS), including its biology, genetics, and risk factors, compared to the pediatric population.
  • To emphasize the lack of standardized treatment protocols for adult RMS and its impact on patient prognosis and overall survival.
  • To explore emerging therapeutic strategies, such as immunotherapy, for adult RMS and advocate for tailored treatment approaches.

Main Methods:

  • Review of existing literature on Rhabdomyosarcoma (RMS) in both pediatric and adult populations.
  • Comparative analysis of the understanding of RMS biology, genetics, and treatment between age groups.
  • Exploration of current and potential future treatment modalities, including immunotherapy.

Main Results:

  • Adult Rhabdomyosarcoma (RMS), especially the pleomorphic subtype, is poorly understood regarding its underlying biology and genetics.
  • Adult RMS patients face a poor prognosis due to low incidence, leading to challenges in research and the absence of standardized treatment plans.
  • Current treatments for adult RMS are not standardized, negatively impacting survival rates compared to other adult sarcomas.

Conclusions:

  • There is a critical need for standardized treatment protocols and further research into the specific biology and genetics of Rhabdomyosarcoma (RMS) in adults.
  • Emerging therapies, including immunotherapy, show promise but require dedicated investigation for effective application in adult RMS patients.
  • Addressing the unique challenges in adult RMS is essential to improve patient outcomes and survival rates, drawing parallels from pediatric successes.